MENU
+Compare
THRD
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$5.43
Change
+$0.01 (+0.18%)
Capitalization
245.04M

THRD Third Harmonic Bio Forecast, Technical & Fundamental Analysis

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases... Show more

THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for THRD with price predictions
Jul 03, 2025

THRD's RSI Oscillator leaves overbought zone

The 10-day RSI Indicator for THRD moved out of overbought territory on June 23, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 instances where the indicator moved out of the overbought zone. In of the 14 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on THRD as a result. In of 62 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for THRD turned negative on June 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 22 similar instances when the indicator turned negative. In of the 22 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where THRD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

THRD broke above its upper Bollinger Band on June 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where THRD advanced for three days, in of 132 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 92 cases where THRD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.899) is normal, around the industry mean (16.672). P/E Ratio (0.000) is within average values for comparable stocks, (58.456). THRD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (269.644).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. THRD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THRD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

THRD is expected to report earnings to fall 34.29% to -23 cents per share on August 07

Third Harmonic Bio THRD Stock Earnings Reports
Q2'25
Est.
$-0.23
Q1'25
Missed
by $0.09
Q4'24
Beat
by $0.05
Q3'24
Missed
by $0.03
Q2'24
Missed
by $0.01
The last earnings report on May 30 showed earnings per share of -34 cents, missing the estimate of -26 cents. With 37.81K shares outstanding, the current market capitalization sits at 245.04M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1700 Montgomery Street
Phone
+1 209 727-2457
Employees
30
Web
https://www.thirdharmonicbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RBSPF6.590.09
+1.39%
NatWest Group plc
CDHSF0.62N/A
N/A
CDL Hospitality Trust
ZLDAF0.28N/A
N/A
Zelira Therapeutics Ltd.
VACBF0.19N/A
N/A
NYKODE THERAPEUTICS AS
TNGCF2.30N/A
N/A
TONGCHENG TRAVEL HLDGS LTD.

THRD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, THRD has been loosely correlated with APGE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if THRD jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THRD
1D Price
Change %
THRD100%
+0.18%
APGE - THRD
42%
Loosely correlated
+7.08%
NVAX - THRD
42%
Loosely correlated
+0.59%
IGMS - THRD
40%
Loosely correlated
+3.03%
ACLX - THRD
35%
Loosely correlated
+1.24%
ADMA - THRD
35%
Loosely correlated
+0.77%
More